- Quest Diagnostics (NYSE:DGX) Q2 results: Revenues: $1,906M (-1.0%); Operating Income: $422M (+40.2%); Net Income: $195M (+65.3%); EPS: $1.37 (+69.1%); Non-GAAP EPS: $1.34 (+7.2%); Quick Assets: $283M (+112.8%); CF Ops: $464M (+37.7%).
- 2016 Guidance: Revenue: $7.47B - 7.54B; GAAP EPS: $4.18 - 4.33; Non-GAAP EPS: $5.02 - 5.17; CF Ops: ~$880M; Adjusted CF Ops: ~$1B; CAPEX: $250M - 300M.
Quest Diagnostics earnings up 65%; Non-GAAP EPS up 7% in Q2; updates guidance
Recommended For You
More Trending News
About DGX Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
DGX | - | - |
Quest Diagnostics Incorporated |